MIRXES-B (2629.HK) 주가

MIRXES-B(2629.HK)는 HKS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 12.41홍콩달러 (+0.00%), 시가총액 37.01억홍콩달러, 52주 범위 12.28홍콩달러 ~ 77.30홍콩달러.

Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China. The company offers GASTROClear, a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening; LUNGClear, a lung cancer screening product candidate; and Fortitude COVID-19 RT-qPCR test kits. It also researches, develops, and manufactures biotechnology, life, and medical science related products. The company was founded in 2014 and is headquartered in Singapore.

핵심 지표

• 현재가: 12.41홍콩달러 (+0.00%)
• 시가총액: 37.01억홍콩달러
• 52주 최저~최고: 12.28홍콩달러 ~ 77.30홍콩달러
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: HKS

MIRXES-B의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

자주 묻는 질문